Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Gilead Sciences Inc (NASDAQ: GILD) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Gilead Sciences Inc (NASDAQ: GILD) concerning whether a series of statements by Gilead Sciences Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On May 27, 2016, Bloomberg stated that Gilead had received a subpoena from the U.S. Attorney for the District of Massachusetts, originally disclosed in the Company's 10-Q for the quarter ended March 31, 2016, requesting documents connected to the Company’s association with certain nonprofits that provide financial assistance to patients. 

Based in Foster City, California, and founded in 1987 Gilead Sciences Inc develops and commercializes medicines in areas of unmet medical needs.

If you purchased shares of Gilead Sciences Inc (NASDAQ: GILD) on or before May 27, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185